Clinical Trial Update: Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses [Phase 3]

View source ↗

Summary

Phase 3 trial comparing GDC 695 and diclofenac sodium gel 3% in actinic keratosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Diclofenac Sodium Gel 3% (diclofenac sodium gel 3%)
• GDC 695

Snippet

Sponsor: Balmoral Medical company | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2019-01-10